BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2923810)

  • 1. Hairy cell leukaemia: observations on natural killer activity in different clinical stages of the disease.
    Demeter J; Pálóczi K; Lehoczky D; Benczúr M
    Br J Haematol; 1989 Feb; 71(2):239-44. PubMed ID: 2923810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cell function and malignant cell phenotype in hairy cell leukaemia.
    Ogmundsdóttir HM; Thorsteinsson L; Sigfússon A; Sveinsdóttir S; Björnsson S; Eyjólfsson G; Jóhannesson GM; Jensson O
    APMIS; 1992 Jan; 100(1):10-20. PubMed ID: 1536717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric study on phagocyte function and determination of in vitro natural killer (NK) cell cytotoxicity in hairy cell leukaemia (HCL). Comparison with values obtained following post-traumatic splenectomy (SP).
    Demeter J; Mihalik R; Pálóczi K; Benczur M
    Acta Paediatr Hung; 1988-1989; 29(1-2):219-20. PubMed ID: 3255408
    [No Abstract]   [Full Text] [Related]  

  • 4. Concomitant effect of 2'-deoxycoformycin on natural killer cell activity and tumour cell sensitivity to lysis in hairy cell leukaemia--discordant effects of alpha interferon.
    Lahat N; Aghai E; Merchav S; Kinarty A; Sobel E; Froom P
    Scand J Immunol; 1990 Aug; 32(2):205-9. PubMed ID: 2389114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and functional characterization of the circulating NK compartment in hairy cell leukaemia.
    Foa R; Lauria F; Lusso P; Raspadori D; Fierro MT; Tazzari PL; Caudana L; Matera L
    Clin Exp Immunol; 1986 May; 64(2):392-8. PubMed ID: 3742880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia.
    Trentin L; Zambello R; Agostini C; Ambrosetti A; Chisesi T; Raimondi R; Bulian P; Pizzolo G; Semenzato G
    Blood; 1990 Apr; 75(7):1525-30. PubMed ID: 2317560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocytes from patients with hairy cell leukaemia enable the distinction of two separate subpopulations of activated lymphocyte killer cells generated in mixed lymphocyte culture.
    Werkmeister JA; Boyd AW; Triglia T; Burns GF
    Clin Exp Immunol; 1985 Jul; 61(1):103-8. PubMed ID: 2931219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased NK activity in hairy cell leukemia (HCL): an analysis at the cellular level.
    Fontana L; De Rossi G; De Sanctis G; Ensoli F; Lopez M; Annino L; Mandelli F
    Blut; 1986 Aug; 53(2):107-13. PubMed ID: 3730622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia.
    Ruco LP; Procopio A; Maccallini V; Calogero A; Uccini S; Annino L; Mandelli F; Baroni CD
    Blood; 1983 Jun; 61(6):1132-7. PubMed ID: 6220750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine-induced enhancement of the susceptibility of hairy cell leukaemia lymphocytes to natural killer cell lysis.
    Cordingley FT; Hoffbrand AV; Brenner MK
    Br J Haematol; 1988 Sep; 70(1):37-41. PubMed ID: 3140887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 12 augments natural killer-cell mediated cytotoxicity in hairy cell leukemia.
    Bigda J; Mysliwska J; Dziadziuszko R; Bigda J; Mysliwski A; Hellmann A
    Leuk Lymphoma; 1993 May; 10(1-2):121-5. PubMed ID: 8104069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 2- and interferon alpha induced natural killer cell activity as a marker of progression in hairy cell leukemia.
    Bigda J; Mysliwska J; Baran W; Hellmann A; Mysliwski A
    Leuk Lymphoma; 1993 Mar; 9(4-5):371-6. PubMed ID: 8348073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer activity and antibody-dependent cellular cytotoxicity in progressive systemic sclerosis.
    Grazia Cifone M; Giacomelli R; Famularo G; Paolini R; Danese C; Napolitano T; Procopio A; Perego AM; Santoni A; Tonietti G
    Clin Exp Immunol; 1990 Jun; 80(3):360-5. PubMed ID: 2372985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer lymphocytes in hairy cell leukemia: presence of phenotypically identifiable cells with defective functional activity.
    Smith BR; Rosenthal DS; Ault KA
    Exp Hematol; 1985 Mar; 13(3):189-93. PubMed ID: 3884356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The beneficial effects of alpha-interferon in hairy cell leukemia are not attributable to NK cell-mediated cytotoxicity.
    Griffiths SD; Cawley JC
    Leukemia; 1987 Apr; 1(4):372-6. PubMed ID: 3669763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hairy-cells are not lysed by NK-cells.
    Sigaux F; Chapuis F; Castaigne S; Degos L; Flandrin G; Gluckman JC
    Blut; 1987 May; 54(5):319-20. PubMed ID: 3567370
    [No Abstract]   [Full Text] [Related]  

  • 17. Interferon alpha-2 for hairy cell leukemia: evidence for induction of RNA synthesis in hairy cells and failure to correlate enhancement of natural killer cells with elimination of hairy cells.
    Schwarzmeier JD; Schwabe M; Prischl F; Wagner L; Lion T; Micksche M; Köller U
    Eur J Haematol; 1987 Nov; 39(5):418-25. PubMed ID: 3691760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host defense deficiency in hairy cell leukemia and its correction by leukocyte transfusion.
    Hersh EM; Murphy S; Zander A; Dicke K; Stewart DJ; Toki H; Latreille J
    Blood; 1980 Sep; 56(3):526-33. PubMed ID: 7407417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An improved method to quantify human NK cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) per IgG FcR-positive NK cell without purification of NK cells.
    Sung AP; Tang JJ; Guglielmo MJ; Redelman D; Smith-Gagen J; Bateman L; Hudig D
    J Immunol Methods; 2018 Jan; 452():63-72. PubMed ID: 29113954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.